Immune checkpoint inhibitors: the emerging cornerstone in cholangiocarcinoma therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver Cancer, 2021 - karger.com
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …
被引用次数：28 相关文章

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver Cancer, 2021 - europepmc.org
Background Cholangiocarcinoma (CCA) encompasses a heterogeneous group of malignant
tumors with dismal prognosis and increasing incidence worldwide. Both late diagnosis due …
[HTML] nih.gov

[HTML][HTML] Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver Cancer, 2021 - ncbi.nlm.nih.gov
Background Cholangiocarcinoma (CCA) encompasses a heterogeneous group of malignant
tumors with dismal prognosis and increasing incidence worldwide. Both late diagnosis due …

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga… - Liver Cancer (2235 …, 2021 - search.ebscohost.com
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …
[HTML] karger.com

[HTML][HTML] Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver Cancer, 2021 - karger.com
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …
[PDF] apef.com.pt

[PDF][PDF] Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

MGLE González-Lópeza, A Roa-Bautistaa… - 2021 - apef.com.pt
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - 2021 - repositorio.unican.es
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Cholangiocarcinoma (CCA) encompasses a heterogeneous group of malignant
tumors with dismal prognosis and increasing incidence worldwide. Both late diagnosis due …

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

M Gutiérrez-Larrañaga, E González-López… - Liver …, 2021 - search.proquest.com
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …
[PDF] apef.com.pt

[PDF][PDF] Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

MGLE González-Lópeza, A Roa-Bautistaa… - 2021 - apef.com.pt
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of
malignant tumors with dismal prognosis and increasing incidence worldwide. Both late …